Clearway Pain Solutions / NexPhase Capital Acquire KureSmart Pain Management from New Harbor Capital

NexPhase Capital Recapitalizes Gulf Coast Pain Institute

March 15, 2018

Healthcare Services

NexPhase Capital has recapitalized Gulf Coast Pain Institute (GCPI); Brown Gibbons Lang & Company served as exclusive financial advisor. The investment launches a national interventional pain management platform called Clearway Pain Solutions Institute that will pursue acquisitions and organic growth across the U.S.; GCPI (founded 2013) operates 11 locations in northwest Florida and offers interventional and non-interventional pain management plus ancillary services.

Clearway Pain Solutions Acquires West Alabama Spine and Pain Specialists

July 31, 2025

Healthcare Services

Clearway Pain Solutions has acquired West Alabama Spine and Pain Specialists, a Tuscaloosa-area pain management practice founded by Dr. Frederick S. Graham. The Tuscaloosa/Northport location will operate under Clearway's The Center for Pain brand, expanding Clearway's footprint in Alabama and preserving the existing clinical team to continue patient care.

Clearway Pain Solutions Acquires Eastern Neurodiagnostic Associates

February 5, 2025

Healthcare Services

Clearway Pain Solutions has acquired Eastern Neurodiagnostic Associates P.C., a multi-specialty neurology and pain management practice serving Southern New Jersey. The practice will continue operating under its existing brand while joining Clearway's Southern New Jersey footprint to expand patient access to neurology, pain management, and neuropsychology services.

CPS Capital Makes Growth Investment in PharmaSmart International

July 12, 2021

Medical Devices

Toronto-based private equity firm CPS Capital made a strategic growth investment in PharmaSmart International alongside the company’s existing management team. The financing (which included term debt from FirePower Capital and Nicola Wealth) will fund roll‑out of PharmaSmart’s PS-2000D health kiosk platform and accelerate expansion across Canada and the United States.

Curewell Capital Majority Investment in Wilmington PharmaTech

October 21, 2025

Pharmaceuticals

Los Angeles-based private equity firm Curewell Capital has made a majority investment in Wilmington PharmaTech (WPT), a U.S.-based specialty CRDMO focused on small-molecule API development and manufacturing. Founder and CEO Hui-Yin "Harry" Li will retain a significant ownership stake and remain as CEO; the capital will be used to expand WPT's U.S. manufacturing capacity, including HPAPI suites, and scale end-to-end API development and manufacturing capabilities.

Capitol Pain Institute (Iron Path Capital-backed) Acquires Nura Pain Clinics

May 3, 2023

Healthcare Services

Capitol Pain Institute (CPI), backed by private equity firm Iron Path Capital, has acquired Nura Pain Clinics to enter the Minneapolis–St. Paul market and expand CPI's national chronic pain platform into Minnesota. The transaction adds Nura's interventional pain management clinics and ambulatory surgical capabilities to CPI's network, broadening access to neuromodulation and implantable pain therapies in the Midwest.